Alvotech News

Barclays Maintains Overweight on Alvotech, Lowers Price Target to $18

BenzingaJul 25 08:42 ET

Alvotech Analyst Ratings

BenzingaJul 25 08:42 ET

Barclays Maintains Alvotech(ALVO.US) With Buy Rating, Cuts Target Price to $18

Moomoo NewsJul 25 05:34 ET

Alvotech Analyst Ratings

BenzingaMay 24 11:02 ET

Alvotech (ALVO) Receives a Buy From Northland Securities

TipRanksMay 23 09:20 ET

Analysts Offer Insights on Healthcare Companies: Talkspace (TALK), Vir Biotechnology (VIR) and Alvotech (ALVO)

TipRanksMay 21 03:56 ET

Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)

TipRanksApr 23 06:11 ET

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Alvotech (ALVO) and Pacific Biosciences (PACB)

TipRanksApr 17 03:35 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)

TipRanksApr 5 03:55 ET

Alvotech Analyst Ratings

BenzingaMar 22 06:42 ET

Alvotech Analyst Ratings

BenzingaJan 29 05:19 ET

Alvotech Upgraded at Citi Citing FDA Nod for Biosimilars

Seeking AlphaOct 20, 2023 10:25 ET

Citigroup Upgrades Alvotech to Neutral, Raises Price Target to $10

BenzingaOct 20, 2023 06:15 ET

Alvotech Analyst Ratings

BenzingaOct 20, 2023 06:14 ET

Citi Upgrades Alvotech (ALVO) to a Hold

TipRanksOct 20, 2023 04:26 ET

Barclays Initiates Coverage On Alvotech With Equal-Weight Rating, Announces Price Target of $10

BenzingaSep 21, 2023 05:09 ET

Alvotech Analyst Ratings

BenzingaSep 21, 2023 05:08 ET

Deutsche Bank Adjusts Alvotech's Price Target to $12 From $8, Maintains Hold Rating

MT NewswiresMar 7, 2023 10:41 ET

Morgan Stanley Starts Alvotech at Equalweight With $10 Price Target

MT NewswiresSep 7, 2022 06:40 ET

Alvotech Price Target Announced at $10.00/Share by Morgan Stanley

Dow JonesSep 7, 2022 05:10 ET